03/03
Headlines

RLYP

Biotech Decliners: Insmed Incorporated (NASDAQ:INSM), 22nd Century Group Inc (NYSEMKT:XXII), Concert Pharmaceuticals Inc (NYSE:JMPC), Relypsa Inc (NASDAQ:RLYP)

Kevin Long02 mins

Insmed Incorporated (NASDAQ:INSM) on May 13, 2014 announces that multiple posterpresentations reporting data on ARIKAYCE(TM), or liposomal amakacinfor inhalation, for the treatment of Pseudomonas aeruginosainfections in cystic fibrosis (CF) patients and for the treatment ofpatients with treatment-resistant nontuberculous mycobacterial (NTM)lung infections will be presented at the American Thoracic SocietyAnnual Meeting 2014, taking place May 16-21…

Read More

Biotech Bullish Stocks: ImmuCell Corporation (NASDAQ:ICCC), TG Therapeutics, Inc. (NASDAQ:TGTX), Relypsa Inc (NASDAQ:RLYP), OHR Pharmaceutical Inc (NASDAQ:OHRP)

Mark DeFrance02 mins

ImmuCell Corporation (NASDAQ:ICCC), a growing animal health company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries, today announced financial results for its first quarter ended March 31, 2014. For the first quarter ended March 31, 2014, ImmuCell Corporation (NASDAQ:ICCC) reported a product sales increase…

Read More

Healthcare Bullish Stocks: Reliv International (NASDAQ:RELV), Flexion Therapeutics (NASDAQ:FLXN), Relypsa Inc (NASDAQ:RLYP), Sucampo Pharmaceuticals (NASDAQ:SCMP)

Jason Knox02 mins

Reliv International, Inc (NASDAQ:RELV) reported net sales of $14.5 million for the first quarter of 2014, compared to net sales of $18.9 million for the first quarter of 2013. Net sales in the United States declined by 29.2 percent for the quarter compared to the same quarter in 2013. Reliv International, Inc (NASDAQ:RELV) stock performance…

Read More